Top Markets
#1 Cortex Cortex +173.96%
#2 Helium Helium +53.83%
#3 GEKKO GEKKO +51.79%
#4 Pons Pons +23.61%
#5 ADO Protocol ADO Protocol +18.10%
#6 o1.exchange o1.exchange +16.40%
#7 Status Status +11.80%
#8 Siren Siren +11.47%
#9 Ontology Gas Ontology Gas +10.14%
#10 Audiera Audiera +9.54%
Coin of the day
Cortex Cortex
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classificação em ações #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Preço da ação
$59.98
Última sincronização: 2024-12-13
Valor de mercado
$1.22B
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Longboard Pharmaceuticals, Inc. (LBPH)

Categoria

Healthcare
Rácio P/B de Longboard Pharmaceuticals, Inc. (LBPH)
Rácio P/B em August 2026 TTM: 33.31
De acordo com os relatórios financeiros mais recentes e o preço das ações da Longboard Pharmaceuticals, Inc., o rácio P/B atual (TTM) é 33.31. No final de 2022, o rácio P/B era 0.91.
Histórico do rácio P/B da Longboard Pharmaceuticals, Inc. de 2020 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
2026 (TTM) 33.31 894.31%
2023 3.35 268.15%
2022 0.91 12.83%
2021 0.81 -85.45%
2020 5.54 0.00%
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -80.96%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -81.26%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -92.48%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -88.87%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH